Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Hemorheol Microcirc ; 62(3): 205-14, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26444596

RESUMO

OBJECTIVE: Incidence of patients requiring complex soft tissue or osseous reconstruction has dramatically increased. However most of the monitoring systems have limitations in tissue penetration and are not able to detect microvascular complications after transplantation of so-called buried-flaps, that have no contact to the surface.Aim of the study was to assess contrast enhanced ultrasound (CEUS) as monitoring tool after buried flap transplantations. METHODS: 20 patients were examined after buried flap transplantation using CEUS. Quantitative perfusion analysis (TIC) was performed with an integrated perfusion software using stored cine-loops. Two perfusion-parameters, time to PEAK (TtoPk) and area under the curve (Area), were evaluated using TIC analysis. RESULTS: Minor complications were observed in 3 patients. In these patients a delayed contrast agent wash-in and wash-out was observed. Additionally the perfusion values TtoPk (sec.) and Area (relative Units) were clearly different in the patients with minor complications: TtoPk: 32.0 sec; Area 425.5 rU (without complication), TtoPk: 38.6 sec.; Area: 18.3 rU (wound healing disturbance) and TtoPk: 14.4 sec.; Area: 105.9 rU (hematoma). CONCLUSION: As CEUS can assess microvascularization almost depth-independent, CEUS is an unique method to assess global flap perfusion after buried flap transplantation.


Assuntos
Meios de Contraste/química , Microcirculação , Perfusão/métodos , Retalhos Cirúrgicos/irrigação sanguínea , Ultrassonografia , Adulto , Idoso , Área Sob a Curva , Artefatos , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Movimento (Física) , Software , Retalhos Cirúrgicos/transplante , Cicatrização
2.
Clin Hemorheol Microcirc ; 58(4): 521-8, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24418866

RESUMO

BACKGROUND: To estimate the presence and severity of capsular contracture in patients after breast implants an objective measurement tool is necessary. PATIENTS AND METHODS: Eleven patients (range of age 37 to 53 years) who underwent cosmetic breast augmentation (seven patients with bilateral implants) or breast reconstruction by mammary asymmetry (four patients unilateral) with smooth silicone gel implants were included in this prospective study. In total seventeen implants were examined clinically and with the colour coded Ultrasound Elastography using a multifrequency probe (5-10 MHz Siemens Antares Premium VFX13-5). The grade of capsular contracture was assessed by two examiners with the palpation method and classified according to the Baker score. The Ultrasound Elastography was performed by two radiologists specialized in breast imaging and was correlated with the Baker score, colour coded ultrasound elastography and a high resolution ultrasound B-scan score (0-5). RESULTS: The clinical examination proved following distribution of the Baker degree: 6 breast implants with Baker grade I and Baker grade II, 3 breast implants with Baker grade III and two breast implants with Baker grade IV. There was a high correlation between the Baker score and the objective scoring measured by Ultrasound Elastography (kappa 0.83-0.89). CONCLUSION: The new technology of Ultrasound Elastography represents a useful tool to evaluate the compressibility of the peri-implant capsule, the implant and the surrounding tissue.


Assuntos
Implantes de Mama/efeitos adversos , Contratura/etiologia , Técnicas de Imagem por Elasticidade/métodos , Adulto , Feminino , Humanos , Pessoa de Meia-Idade
3.
Clin Exp Allergy ; 20(2): 171-4, 1990 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1972648

RESUMO

Cetirizine is a new selective H1-antagonist. In a double-blind and placebo-controlled study, 11 subjects underwent a conjunctival provocation test (CPT) with a grass pollen extract to determine the effect of cetirizine on allergen-induced itching and redness of the eye. Results of CPTs were reproducible, as no difference was observed between the CPTs performed without any pre-treatment and the CPTs after placebo. Compared to placebo, cetirizine administered orally (10 mg twice a day for 4 days) and in double-blind fashion increased the conjunctival reaction threshold (P less than 0.004) by inhibiting both redness and itching of the eye. Cetirizine should protect patients against allergic conjunctivitis.


Assuntos
Alérgenos/administração & dosagem , Conjuntivite Alérgica/tratamento farmacológico , Hidroxizina/análogos & derivados , Adolescente , Adulto , Cetirizina , Ensaios Clínicos como Assunto , Conjuntivite Alérgica/diagnóstico , Conjuntivite Alérgica/etiologia , Método Duplo-Cego , Feminino , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Humanos , Hidroxizina/uso terapêutico , Testes Imunológicos , Masculino , Pólen/imunologia , Rinite Alérgica Sazonal/diagnóstico , Rinite Alérgica Sazonal/tratamento farmacológico , Rinite Alérgica Sazonal/etiologia
4.
Artigo em Inglês | MEDLINE | ID: mdl-2449381

RESUMO

We report four cases of corneoconjunctival keratinization that were successfully treated with topical retinoic acid ointment. In two cases keratinization was due to squamous metaplasia and in two others it was secondary to intraepithelial corneoconjunctival neoplasia. Treatment reversed severe keratinization in a case of drug-induced pseudopemphigoid and stabilized the disease in one of the two affected eyes without additional treatment. In a case of ocular cicatricial pemphigoid, retinoic acid was useful as an adjuvant therapy to immunosuppression, by reversing keratinization of the conjunctiva. In two cases of corneoconjunctival neoplasia, lesions regressed markedly. Long-term treatment was well tolerated in three patients. Our findings suggest that retinoic acid ointment is effective in treating severe squamous metaplasia in cicatrizing diseases of the conjunctiva. Our findings indicate further that retinoic acid seems to inhibit growth of corneoconjunctival neoplasias and thus might be useful complementary therapy in this situation.


Assuntos
Túnica Conjuntiva/metabolismo , Doenças da Túnica Conjuntiva/tratamento farmacológico , Córnea/metabolismo , Doenças da Córnea/tratamento farmacológico , Queratinas/metabolismo , Tretinoína/uso terapêutico , Administração Tópica , Idoso , Idoso de 80 Anos ou mais , Doenças da Túnica Conjuntiva/patologia , Neoplasias da Túnica Conjuntiva/tratamento farmacológico , Conjuntivite/tratamento farmacológico , Conjuntivite/patologia , Doenças da Córnea/patologia , Epitélio/metabolismo , Epitélio/patologia , Feminino , Humanos , Masculino , Metaplasia/tratamento farmacológico , Tretinoína/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...